Phenotype
|
Fish
|
Conditions
|
Figures
|
blood vessel endothelial cell increased amount, abnormal
|
WT + MO3-dll4
|
standard conditions
|
Fig. 2
from Leslie et al., 2007
|
lymphangioblast cord absent, abnormal
|
WT + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 2
from Geudens et al., 2010
|
lymphangioblast cord absent, abnormal
|
hu4453Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 2
from Geudens et al., 2010
|
regulation of blood vessel endothelial cell migration disrupted, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. 3
from Leslie et al., 2007
|
trunk vasculature branchiness, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. S8
from Fukui et al., 2009
|
intersegmental vessel morphology, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. 2 ,
Fig. 3
from Leslie et al., 2007
|
posterior cardinal vein morphology, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. 2
from Leslie et al., 2007
|
pericardium edematous, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. S8
from Fukui et al., 2009
|
intersegmental vessel cell increased amount, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. S8
from Fukui et al., 2009
|
dorsal aorta morphology, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. 2
from Leslie et al., 2007
|
cranial vasculature branchiness, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. S8
from Fukui et al., 2009
|
blood circulation decreased rate, abnormal
|
y1Tg + MO3-dll4
|
standard conditions
|
Fig. 2
from Leslie et al., 2007
|
thoracic duct wholeness, abnormal
|
y1Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 1,
Fig. 4
from Geudens et al., 2010
|
lymphangiogenesis disrupted, abnormal
|
y1Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 1,
Fig. 4
from Geudens et al., 2010
|
thoracic duct absent, abnormal
|
y1Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 1
from Geudens et al., 2010
|
branching involved in lymph vessel morphogenesis disrupted, abnormal
|
y1Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 4
from Geudens et al., 2010
|
lymphangiogenic sprout decreased amount, abnormal
|
y1Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 4
from Geudens et al., 2010
|
venous endothelial cell migration involved in lymph vessel development disrupted, abnormal
|
y1Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 4
from Geudens et al., 2010
|
thoracic duct hypotrophic, abnormal
|
y1Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 4
from Geudens et al., 2010
|
lymphangioblast cord absent, abnormal
|
y1Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 4
from Geudens et al., 2010
|
intersegmental artery absent, abnormal
|
hu4624Tg; s916Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 2
from Geudens et al., 2010
|
intersegmental vessel has extra parts of type intersegmental vein, abnormal
|
hu4624Tg; s916Tg + MO3-dll4 + MO4-dll4
|
standard conditions
|
Fig. 2
from Geudens et al., 2010
|
intersegmental vessel has extra parts of type endothelial cell, abnormal
|
ncv3Tg; ncv5Tg + MO3-dll4
|
standard conditions
|
Fig. 3
from Fukuhara et al., 2014
|
endothelial cell cytoplasm GCaMP expression spatial pattern, abnormal
|
ncv31Tg; ubs4Tg; zf415Tg + MO3-dll4
|
standard conditions
|
Fig. 10
from Yokota et al., 2015
|
endothelial tip cell GCaMP expression spatial pattern, abnormal
|
ncv31Tg; ubs4Tg; zf415Tg + MO3-dll4
|
standard conditions
|
Fig. 8
from Yokota et al., 2015
|
trunk vasculature blood vessel endothelial cell mCherry expression decreased amount, abnormal
|
ncv69Tg; s939Tg + MO3-dll4
|
standard conditions
|
Fig. 4
from Ando et al., 2019
|
intersegmental vessel decreased length, ameliorated
|
s843Tg + MO1-egfl6 + MO3-dll4
|
standard conditions
|
Fig. 7
from Wang et al., 2016
|
intersegmental vessel endothelial cell amount, ameliorated
|
y7Tg + MO1-egfl6 + MO3-dll4
|
standard conditions
|
Fig. 7
from Wang et al., 2016
|
intersegmental vein vascular sprouts increased amount, exacerbated
|
flt1ka601/ka601; s843Tg + MO3-dll4
|
standard conditions
|
Fig. 5
from Wild et al., 2017
|
intersegmental vein increased amount, abnormal
|
flt1ka601/ka601; s843Tg + MO3-dll4
|
standard conditions
|
Fig. 5
from Wild et al., 2017
|
intersegmental vein dorsal region branchiness, exacerbated
|
flt1ka601/ka601; s843Tg + MO3-dll4
|
standard conditions
|
Fig. 5
from Wild et al., 2017
|
intersegmental vessel vascular sprouts increased amount, exacerbated
|
flt1ka601/ka601; s843Tg + MO3-dll4
|
standard conditions
|
Fig. 5
from Wild et al., 2017
|
intersegmental vessel dorsal region branchiness, exacerbated
|
flt1ka601/ka601; s843Tg + MO3-dll4
|
standard conditions
|
Fig. 5
from Wild et al., 2017
|
intersegmental artery decreased amount, abnormal
|
flt1ka601/ka601; s843Tg + MO3-dll4
|
standard conditions
|
Fig. 5
from Wild et al., 2017
|
intersegmental vessel endothelial cell amount, ameliorated
|
s916Tg; y7Tg + MO1-itgb1a + MO3-dll4
|
standard conditions
|
Fig. 7
from Wang et al., 2016
|
intersegmental vessel decreased length, ameliorated
|
s916Tg; y7Tg + MO1-itgb1a + MO3-dll4
|
standard conditions
|
Fig. 7
from Wang et al., 2016
|